Subtle Gray Matter Changes in Temporo-Parietal Cortex Associated with Cardiovascular Risk Factors

Show simple item record

dc.contributor Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.author DE TOLEDO FERRAZ ALVES, Tania Correa FMUSP-HC
SCAZUFCA, Marcia FMUSP-HC
SQUARZONI, Paula FMUSP-HC
DE SOUZA DURAN, Fabio Luiz FMUSP-HC
TAMASHIRO-DURAN, Jaqueline Hatsuko FMUSP-HC
VALLADA, Homero P. FMUSP-HC
ANDREI, Anna
WAJNGARTEN, Mauricio FMUSP-HC
MENEZES, Paulo R. FMUSP-HC
BUSATTO, Geraldo F. FMUSP-HC
dc.date.issued 2011
dc.identifier.citation JOURNAL OF ALZHEIMERS DISEASE, v.27, n.3, p.575-589, 2011
dc.identifier.issn 1387-2877
dc.identifier.uri http://observatorio.fm.usp.br/handle/OPI/6486
dc.description.abstract Vascular risk factors may play an important role in the pathophysiology of Alzheimer's disease (AD). While there is consistent evidence of gray matter (GM) abnormalities in earlier stages of AD, the presence of more subtle GM changes associated with vascular risk factors in the absence of clinically significant vascular events has been scarcely investigated. This study aimed to examine GM changes in elderly subjects with cardiovascular risk factors. We predicted that the presence of cardiovascular risk would be associated with GM abnormalities involving the temporal-parietal cortices and limbic structures. We recruited 248 dementia-free subjects, age range 66-75 years, from the population-based "Sao Paulo Ageing and Health Study", classified in accordance to their Framingham Coronary Heart Disease Risk (FCHDR) score to undergo an MRI scan. We performed an overall analysis of covariance, controlled to total GM and APOE4 status, to investigate the presence of regional GM abnormalities in association with FCHDR subgroups (high-risk, medium-risk, and low-risk), and followed by post hoc t-test. We also applied a co-relational design in order to investigate the presence of linear progression of the GM vulnerability in association with cardiovascular risk factor. Voxel-based morphometry showed that the presence of cardiovascular risk factors were associated with regional GM loss involving the temporal cortices bilaterally. Those results retained statistical significance after including APOE4 as a covariate of interest. We also observed that there was a negative correlation between FCHDR scores and rGM distribution in the parietal cortex. Subclinical cerebrovascular abnormalities involving GM loss may provide an important link between cardiovascular risk factors and AD.
dc.description.sponsorship · Wellcome Trust, UK [GR066133MA]
· FAPESP, Brazil [04/15336-5, 2004/12694-8]
· CNPQ-Brazil
dc.language.iso eng
dc.publisher IOS PRESS
dc.relation.ispartof JOURNAL OF ALZHEIMERS DISEASE
dc.rights openAccess
dc.subject Alzheimer's disease; elderly; MRI; population-based; vascular risk factors
dc.subject.other CORONARY-HEART-DISEASE; VASCULAR COGNITIVE IMPAIRMENT; VOXEL-BASED MORPHOMETRY; TRAUMATIC BRAIN-INJURY; MIDLIFE BLOOD-PRESSURE; ALZHEIMERS-DISEASE; WHITE-MATTER; METABOLIC SYNDROME; APOE GENOTYPE; CEREBRAL HYPOPERFUSION
dc.title Subtle Gray Matter Changes in Temporo-Parietal Cortex Associated with Cardiovascular Risk Factors
dc.type article
dc.rights.holder Copyright IO PRESS
dc.description.group LIM/21
dc.description.group LIM/23
dc.description.group LIM/39
dc.identifier.doi 10.3233/JAD-2011-110827
dc.identifier.pmid 21841245
dc.type.category original article
dc.type.version publishedVersion
hcfmusp.author DE TOLEDO FERRAZ ALVES, Tania Correa:HC:LIM/21
hcfmusp.author SCAZUFCA, Marcia:HC:LIM/23
hcfmusp.author SQUARZONI, Paula:FM:
hcfmusp.author DE SOUZA DURAN, Fabio Luiz:HC:LIM/21
hcfmusp.author TAMASHIRO-DURAN, Jaqueline Hatsuko:HC:LIM/21
hcfmusp.author VALLADA, Homero P.:FM:MPS
hcfmusp.author WAJNGARTEN, Mauricio:HC:INCOR
hcfmusp.author MENEZES, Paulo R.:FM:MPR
hcfmusp.author BUSATTO, Geraldo F.:FM:MPS
hcfmusp.author.external · ANDREI, Anna: Cardiological Institute, General Hospital of University of Sao Paulo Medical School
hcfmusp.origem.id 2-s2.0-82555184980
hcfmusp.origem.id WOS:000297865800012
hcfmusp.publisher.city AMSTERDAM
hcfmusp.publisher.country NETHERLANDS
hcfmusp.relation.reference · Almeida JRC, 2005, BRAZ J MED BIOL RES, V38, P431, DOI 10.1590/S0100-879X2005000300014
· Almeida OP, 2008, AM J GERIAT PSYCHIAT, V16, P92, DOI 10.1097/JGP.0b013e318157cad2
· ALVES TCD, J ALZHEIMERS DIS, V20, P749
· Alves TCDF, 2006, NEUROL RES, V28, P579, DOI 10.1179/016164106X130416
· Alves TCTF, 2005, J NEUROIMAGING, V15, P150, DOI 10.1177/1051228404272880
· Biessels GJ, 2006, J NEUROL NEUROSUR PS, V77, P304, DOI 10.1136/jnnp.2005.069583
· Borch-Johnsen K, 2007, DAN MED BULL, V54, P157
· Brett M, 2002, NAT REV NEUROSCI, V3, P243, DOI 10.1038/nrn756
· Cechetto David F, 2008, Expert Rev Neurother, V8, P743, DOI 10.1586/14737175.8.5.743
· Chamorro A, 1996, STROKE, V27, P388
· Chen XH, 2006, PSYCHIAT RES-NEUROIM, V147, P105, DOI 10.1016/j.pscychresns.2006.01.009
· Cherbuin N, 2008, J GERONTOL A-BIOL, V63, P501
· Craft S, 2009, ARCH NEUROL-CHICAGO, V66, P300, DOI 10.1001/archneurol.2009.27
· Curiati PK, 2009, AM J NEURORADIOL, V30, P1850, DOI 10.3174/ajnr.A1727
· DeCarli C, 2005, NEUROBIOL AGING, V26, P491, DOI 10.1016/j.neurobiolaging.2004.05.004
· De Jong GI, 1999, NEUROSCIENCE, V91, P203, DOI 10.1016/S0306-4522(98)00659-9
· DeJong GI, 1997, ANN NY ACAD SCI, V826, P56
· de la Torre JC, 2000, NEUROBIOL AGING, V21, P331, DOI 10.1016/S0197-4580(00)00111-1
· de la Torre JC, 2008, NEURODEGENER DIS, V5, P126, DOI 10.1159/000113681
· de la Torre JC, 2009, INT REV NEUROBIOL, V84, P35, DOI 10.1016/S0074-7742(09)00403-6
· De La Torre JC, 2002, ANN NY ACAD SCI, V977, P196
· DELATORRE JC, 1992, BRAIN RES, V582, P186, DOI 10.1016/0006-8993(92)90132-S
· den Heijer T, 2003, DIABETOLOGIA, V46, P1604, DOI 10.1007/s00125-003-1235-0
· Elias MF, 1997, EXP AGING RES, V23, P201, DOI 10.1080/03610739708254281
· Eriksson SH, 2009, HUM BRAIN MAPP, V30, P3351, DOI 10.1002/hbm.20757
· Erkinjuntti Timo, 2009, V24, P79, DOI 10.1159/000197886
· Erten-Lyons D, 2009, NEUROLOGY, V72, P354, DOI 10.1212/01.wnl.0000341273.18141.64
· Espeseth T, 2008, NEUROBIOL AGING, V29, P329, DOI 10.1016/j.neurobiolaging.2006.10.030
· Espeseth T, 2006, COGN AFFECT BEHAV NE, V6, P31, DOI 10.3758/CABN.6.1.31
· Farkas E, 2004, BRAIN RES, V1008, P252, DOI 10.1016/j.brainres.2004.02.037
· Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BRM.41.4.1149
· Ferri CP, 2005, LANCET, V366, P2112
· Fitzpatrick AL, 2009, ARCH NEUROL-CHICAGO, V66, P336, DOI 10.1001/archneurol.2008.582
· Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074
· Garrido GEJ, 2002, J NEUROL NEUROSUR PS, V73, P508, DOI 10.1136/jnnp.73.5.508
· Giannakopoulos P, 2009, STROKE, V40, P983, DOI 10.1161/STROKEAHA.108.530337
· Giele JLP, 2004, STROKE, V35, P742, DOI 10.1161/01.STR.0000117572.56058.2A
· Glatt SJ, 2007, BIOL PSYCHIAT, V62, P282, DOI 10.1016/j.biopsych.2006.09.015
· Gold SM, 2007, DIABETOLOGIA, V50, P711, DOI 10.1007/s00125-007-0602-7
· Good CD, 2002, NEUROIMAGE, V17, P29, DOI 10.1006/nimg.2002.1202
· Grundy SM, 1998, CIRCULATION, V97, P1876
· Gudbjornsdottir S, 2009, DIABETIC MED, V26, P53, DOI 10.1111/j.1464-5491.2008.02633.x
· Henskens LH, 2009, J HYPERTENS, V27, P1446, DOI 10.1097/HJH.0b013e32832b5204
· Hiekikanen H, 2007, BRAIN INJURY, V21, P1307, DOI 10.1080/02699050701739549
· HONEA RA, NEUROLOGY, V74, P113
· Honea RA, 2009, J ALZHEIMERS DIS, V18, P553, DOI 10.3233/JAD-2009-1163
· Inoue Kazuo, 2007, J Stroke Cerebrovasc Dis, V16, P14, DOI 10.1016/j.jstrokecerebrovasdis.2006.08.001
· Inoue T, 1996, DIABETES RES CLIN PR, V31, P81, DOI 10.1016/0168-8227(96)01196-5
· Irie F, 2008, ARCH NEUROL-CHICAGO, V65, P89, DOI 10.1001/archneurol.2007.29
· Isoniemi H, 2006, NEUROLOGY, V67, P756, DOI 10.1212/01.wnl.0000234140.64954.12
· Ito Hirono, 2008, J Stroke Cerebrovasc Dis, V17, P35, DOI 10.1016/j.jstrokecerebrovasdis.2007.11.002
· Jeerakathil T, 2004, STROKE, V35, P1857, DOI 10.1161/01.STR.0000135226.53499.85
· Kalaria RN, 2008, LANCET NEUROL, V7, P812, DOI 10.1016/S1474-4422(08)70169-8
· Kannel WB, 1997, ADV INTERNAL MED, V42, P39
· Kappagoda CT, 2009, J CARDIOPULM REHABIL, V29, P207, DOI 10.1097/HCR.0b013e3181af6be5
· Kim SH, 2006, J AM COLL CARDIOL, V48, P293, DOI 10.1016/j.jacc.2006.03.043
· Kivipelto M, 2008, J CELL MOL MED, V12, P2762, DOI 10.1111/j.1582-4934.2008.00296.x
· Knopman D, 2001, NEUROLOGY, V56, P42
· Knopman DS, 2005, NEUROLOGY, V65, P876, DOI 10.1212/01.wnl.0000176074.09733.a8
· Koga H, 2009, J STROKE CEREBROVASC, V18, P32, DOI 10.1016/j.jstrokecerebrovasdis.2008.07.010
· Korf ESC, 2006, DIABETES CARE, V29, P2268, DOI 10.2337/dc06-0243
· Korf ESC, 2004, HYPERTENSION, V44, P29, DOI 10.1161/01.HYP.0000132475.32317.bb
· Korf ESC, 2007, DIABETIC MED, V24, P166, DOI 10.1111/j.1464-5491.2007.02049.x
· Kuczynski B, 2009, NEUROLOGY, V72, P738, DOI 10.1212/01.wnl.0000343005.35498.e5
· Kuller LH, 1998, STROKE, V29, P388
· Kumar A, 2008, J MAGN RESON IMAGING, V27, P14, DOI 10.1002/jmri.21224
· Kwon HM, 2006, STROKE, V37, P466, DOI 10.1161/01.STR.0000199081.17935.81
· Last D, 2007, DIABETES CARE, V30, P1193, DOI 10.2337/dc06-2052
· Launer LJ, 2000, NEUROBIOL AGING, V21, P49, DOI 10.1016/S0197-4580(00)00096-8
· Launer LJ, 2009, STROKE, V40, pS53, DOI 10.1161/STROKEAHA.108.533075
· Lopez OL, 2008, NEUROLOGY, V70, P1664, DOI 10.1212/01.wnl.0000306696.82017.66
· Luchsinger JA, 2005, NEUROLOGY, V65, P545, DOI 10.1212/01.wnl.0000172914.08967.dc
· MANOLIO TA, 1994, STROKE, V25, P318
· Massaro JM, 2004, STAT MED, V23, P351, DOI 10.1002/sim.1743
· Matsuda H, 2007, J NUCL MED, V48, P1289, DOI 10.2967/jnumed.106.037218
· Mercuro Giuseppe, 2003, Ital Heart J, V4, P363
· Meyer JS, 2000, ANN NY ACAD SCI, V903, P411, DOI 10.1111/j.1749-6632.2000.tb06393.x
· Miura K, 2009, CIRCULATION, V119, P1892, DOI 10.1161/CIRCULATIONAHA.108.823112
· Mosconi L, 2007, EXP GERONTOL, V42, P129, DOI 10.1016/j.exger.2006.05.016
· Mosconi Lisa, 2004, Expert Rev Neurother, V4, P831, DOI 10.1586/14737175.4.5.831
· Mueller SG, 2008, NEUROIMAGE, V42, P42, DOI 10.1016/j.neuroimage.2008.04.174
· Prince M, 2004, INT J GERIATR PSYCH, V19, P178, DOI 10.1002/gps.1059
· Prince M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-165
· Qiu Chengxuan, 2009, Dialogues Clin Neurosci, V11, P111
· Rafnsson SB, 2009, VASC MED, V14, P51, DOI 10.1177/1358863X08095027
· Rasgon NL, 2011, NEUROBIOL AGING, V32, P1942, DOI 10.1016/j.neurobiolaging.2009.12.005
· Raz N, 2007, ANN NY ACAD SCI, V1097, P84, DOI 10.1196/annals.1379.018
· Razay G, 2007, ARCH NEUROL-CHICAGO, V64, P93, DOI 10.1001/archneur.64.1.93
· Reiman EM, 2007, ANN NY ACAD SCI, V1097, P94, DOI 10.1196/annals.1379.011
· Riello R, 2005, AGING CLIN EXP RES, V17, P329
· Rimajova M, 2008, J ALZHEIMERS DIS, V13, P137
· Romero JR, 2009, STROKE, V40, P1590, DOI 10.1161/STROKEAHA.108.535245
· Roquer J, 2009, CEREBROVASC DIS, V27, P25, DOI 10.1159/000200439
· Rosendoff C, 2007, AM J GERIATR CARDIOL, V16, P143, DOI 10.1111/j.1076-7460.2007.06696.x
· Rutter MK, 2005, DIABETES, V54, P3252, DOI 10.2337/diabetes.54.11.3252
· Salat DH, 2009, NEUROIMAGE, V44, P1247, DOI 10.1016/j.neuroimage.2008.10.030
· Sawada H, 2000, J NEUROL NEUROSUR PS, V68, P653, DOI 10.1136/jnnp.68.5.653
· Scazufca M, 2008, INT PSYCHOGERIATR, V20, P394, DOI 10.1017/S1041610207005625
· SCAZUFCA M, 2007, INT PSYCHOGERIATR, V17, P1
· Scazufca M, 2008, INT J EPIDEMIOL, V37, P721, DOI 10.1093/ije/dym154
· Scazufca M, 2008, INT J EPIDEMIOL, V37, P879, DOI 10.1093/ije/dyn125
· Schuff N, 2009, BRAIN, V132, P1067, DOI 10.1093/brain/awp007
· Seshadri S, 2004, NEUROLOGY, V63, P1591
· Seshadri S, 2006, INT REV PSYCHIATR, V18, P409, DOI 10.1080/09540260600935413
· Sethi Ankur, 2008, Exp Clin Cardiol, V13, P113
· Shintani S, 1998, J NEUROL SCI, V160, P82, DOI 10.1016/S0022-510X(98)00182-8
· Sonnen JA, 2009, ARCH NEUROL-CHICAGO, V66, P315, DOI 10.1001/archneurol.2008.579
· Stuerenburg HJ, 2005, NEUROENDOCRINOL LETT, V26, P261
· Szekely CA, 2008, NEUROLOGY, V70, P17, DOI 10.1212/01.wnl.0000284596.95156.48
· Taki Y, 2008, OBESITY, V16, P119, DOI 10.1038/oby.2007.4
· Teipel SJ, 2009, J ALZHEIMERS DIS, V17, P571, DOI 10.3233/JAD-2009-1077
· Terribilli D, 2011, NEUROBIOL AGING, V32, P354, DOI 10.1016/j.neurobiolaging.2009.02.008
· Tiehuis AM, 2008, STROKE, V39, P1600, DOI 10.1161/STROKEAHA.107.506089
· Tonstad S, 2003, J CARDIOVASC RISK, V10, P129, DOI 10.1097/01.hjr.0000060836.46105.ae
· Uehara T, 1999, STROKE, V30, P378
· Using nontraditional risk factors in coronary heart disease risk assessment, 2009, ANN INTERN MED, V151, P474
· van der Flier WM, 2005, STROKE, V36, P2116, DOI 10.1161/01.STR.0000179092.59909.42
· Viswanathan A, 2009, NEUROLOGY, V72, P368, DOI 10.1212/01.wnl.0000341271.90478.8e
· Wessels AM, 2006, DIABETOLOGIA, V49, P2474, DOI 10.1007/s00125-006-0283-7
· Wilson PWF, 1998, CIRCULATION, V97, P1837
· Wisdom NM, 2011, NEUROBIOL AGING, V32, P63, DOI 10.1016/j.neurobiolaging.2009.02.003
· Xu GF, 2009, BRAIN, V132, P383, DOI 10.1093/brain/awn254
· Xu WL, 2009, DIABETES, V58, P71, DOI 10.2337/db08-0586
· Yakushev I, 2009, NEUROIMAGE, V44, P43, DOI 10.1016/j.neuroimage.2008.07.015
· Yang K, 2009, DIABETES EDUCATOR, V35, P770, DOI 10.1177/0145721709338528
· Ystad Martin A, 2009, BMC Med Imaging, V9, P17, DOI 10.1186/1471-2342-9-17
· Zivadinov R, 2009, NEUROLOGY, V73, P504, DOI 10.1212/WNL.0b013e3181b2a706
dc.description.index MEDLINE
hcfmusp.citation.scopus 16
hcfmusp.scopus.lastupdate 2021-09-17


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace



Browse

My Account

Statistics